Navigation Links
Life Sciences Leaders to Launch Statewide 'We Work for Health' Economic Development and Jobs Campaign
Date:4/20/2009

Group to Release Groundbreaking Study on Economic Impact of Life Sciences Sector on Washington State

SEATTLE, April 20 /PRNewswire/ -- An alliance of Washington state business, academic, government and community leaders will launch "We Work for Health," a landmark statewide effort to enhance the public's understanding of the economic impact of Washington's life sciences industry and to promote the growth and success of the sector.

We Work for Health will release the results of a groundbreaking study demonstrating the economic impact of the life sciences and biopharmaceutical sector in Washington state. The study will highlight the number of jobs created directly and indirectly by the biotechnology, biopharmaceutical, biomedical and research companies that make Washington an international hub for life sciences innovation.

WHAT

News conference to launch We Work for Health, a statewide economic development and jobs advocacy coalition.

Release of job creation and economic impact study by Archstone Consulting of biopharmaceutical and related industries in Washington state.

Tour of Seattle Children's Research Institute to illustrate importance of life sciences jobs in Washington state.

    WHEN
    Thursday, April 23, 2009
    10 a.m. News Conference
    10:45 a.m. Tour of Seattle Children's Research Institute with President James B. Hendricks, PhD.

    WHERE
    Seattle Children's Research Institute
    Soundgarden Room, 11th floor
    1900 9th Ave.
    Seattle, WA 98101

Complimentary parking is available in the Diamond Parking garage in the Children's building. The entrance is located in the alley off Stewart Street between 9th and Terry.

WHO

We Work for Health Co-Chairs

  • Bob Drewel, Executive Director, Puget Sound Regional Council
  • Dr. Elson S. Floyd, President, Washington State University
  • Dr. Lee Huntsman, Executive Director, Life Sciences Discovery Fund
  • Chris Rivera, President, Washington Biotechnology and Biomedical Association
  • Rogers Weed, Director of the Washington State Department of Community, Trade and Economic Development

Presenter

Michael Eckstut, Life Sciences Practice Leader, Archstone Consulting

BACKGROUND

We Work for Health is a statewide effort uniting organizations, companies, individuals and other stakeholders around a common goal: to educate policymakers and key opinion leaders about the economic impact of the life sciences innovation pipeline and to promote and grow the industry in Washington state. We Work for Health seeks to raise awareness of the impact of public policy on innovation in the life sciences, related industries and surrounding communities.

Media Contacts: Chelsea Waliser or Nate Cole-Daum, Nyhus Communications LLC for We Work for Health, (206) 323-3733 | chelsea@nyhus.com or nate@nyhus.com


'/>"/>
SOURCE We Work for Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Caliper Life Sciences First Quarter 2009 Financial Results Conference Call Notice
2. Gene Network Sciences Announces Brain Cancer Collaboration With M.D. Anderson
3. HBO, UCSD Shiley-Marcos Alzheimers Disease Research Center, The Alzheimers Association San Diego/Imperial Chapter and The Neurosciences Institute Present an Advance Screening of THE ALZHEIMERS PROJECT: MOMENTUM IN SCIENCE
4. Gene Network Sciences Names Departing Merck Head of Genetics Eric Schadt as Co-Chair of Scientific Advisory Board
5. Advanced Life Sciences Announces Results of Shareholder Meeting and Provides Additional Information on Upcoming Advisory Committee Meeting
6. Stem Cell Biotherapy Sues Casey Nabavi, Co-Founder and Former President, for Conduct Resulting in Claims by SCB Patients Against Nabavi, Embezzling Money and Converting Other Assets Belonging to SCB and for Wrongfully Establishing Cellulogix Biosciences t
7. Derma Sciences Reports Fourth Quarter, Year-End Results for 2008
8. Human Pheromone Sciences Announces Fourth Quarter and Full Year Results
9. ReGear Life Sciences Closes $2.5 Million in Series A Financing Following $1M Investment by Stonewood Capital Management, Inc.
10. Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS)
11. Derma Sciences to Report 2008 Fourth Quarter and Year-End Results on April 1, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Seattle, WA, and Washington, DC (PRWEB) , ... ... ... PATH and the Siemens Foundation today announced a new initiative—the Siemens ... technologies for low-resource settings. The partnership will recruit top students from U.S. ...
(Date:2/12/2016)... Falls Church, VA (PRWEB) , ... February 12, 2016 , ... CDRH Enforcement Trends: , ... http://www.fdanews.com/cdrhenforcementtrends , As Winston Churchill said, “Those who don’t learn ... 2015 will show what to expect when they come knocking this year. But that takes ...
(Date:2/12/2016)... ... February 12, 2016 , ... Each year, the American Physical Therapy Association ... CA at the Anaheim Convention Center. Almost 10,000 physical therapists across the country are ... action, learn more about their chosen field and network with their colleagues. As ...
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker ... Red Carpet Events LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and ... hydrated before the big event. The invitation-only gifting suite, held this year at the ...
(Date:2/12/2016)... Appleton, Wis. (PRWEB) , ... February 12, 2016 ... ... its second Lean Leadership Series at Zuckerberg San Francisco General Hospital on April ... to practice new behaviors and create new habits. The workshops cover a broad ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , 12 februari 2016 ... een toonaangevende leverancier van productie en ontwikkeling ... industrieën, kondigt vandaag een uitbreiding aan van ... haar locatie in Charleston, SC ... geleid tot meerdere recente investeringen. ...
(Date:2/11/2016)... -- The primary goal of this research is to ... usage of liquid biopsy. Key information the survey seeks ... of liquid biopsy adoption amidst future users - Predominantly ... - Sample inflow to conduct liquid biopsy tests - ... so on. - Correlation analysis of sample type and ...
(Date:2/11/2016)... 11, 2016  Walgreens has committed to provide drug ... Washington, D.C. as part of a ... commended by shareholder advocacy organization As You Sow. ... "Many people hold on to unneeded drugs because they lack ... consequences." --> Conrad MacKerron , Senior Vice ...
Breaking Medicine Technology: